Evaluation of Experimental Designs for Two-Color cDNA Microarrays

The major goal of two-color cDNA microarray experiments is to measure the relative gene expression level (i.e., relative amount of mRNA) of each gene between samples in studies of gene expression. More specifically, given an N-sample experiment, we need all N(N - 1)/2 relative expression levels of all sample pairs of each gene for identification of the differentially expressed genes and for clustering of gene expression patterns. However, the intensities observed from two-color cDNA microarray experiments do not simply represent the relative gene expression level. They are composed of signal (gene expression level), noise, and other factors. In discussions on the experimental design of two-color cDNA microarray experiments, little attention has been given to the fact that different combinations of test and control samples will produce microarray intensities data with varying intrinsic composition of factors. As a consequence, not all experimental designs for two-color cDNA microarray experiments are able to provide all possible relative gene expression levels. This phenomenon has never been addressed. To obtain all possible relative gene expression levels, a novel method for two-color cDNA microarray experimental design evaluation is necessary that will allow the making of an accurate choice. In this study, we propose a model-based approach to illustrate how the factor composition of microarray intensities changed with different experimental designs in two-color cDNA microarray experiments. By analyzing 12 experimental designs (including 5 general forms), we demonstrate that not all experimental designs are able to provide all possible relative gene expression levels due to the differences in factor composition. Our results indicate that whether an experimental design can provide all possible relative expression levels of all sample pairs for each gene should be the first criterion to be considered in an evaluation of experimental designs for two-color cDNA microarray experiments.

[1]  G. Churchill.  Fundamentals of experimental design for cDNA microarrays , 2002, Nature Genetics.

[2]  Stanley Falkow,et al.  Host microarray analysis reveals a role for the Salmonella response regulator phoP in human macrophage cell death , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[3]  T. Speed,et al.  Design issues for cDNA microarray experiments , 2002, Nature Reviews Genetics.

[4]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[5]  D. Botstein,et al.  The transcriptional program in the response of human fibroblasts to serum. , 1999, Science.

[6]  D. Slonim.  From patterns to pathways: gene expression data analysis comes of age , 2002, Nature Genetics.

[7]  D. Jones,et al.  Adjustments and measures of differential expression for microarray data , 2002, Bioinform..

[8]  H. Greenberg,et al.  Gene Expression Pattern in Caco-2 Cells following Rotavirus Infection , 2002, Journal of Virology.

[9]  Rui Li,et al.  Comprehensive analysis of the gene expression profiles in human gastric cancer cell lines , 2002, Oncogene.

[10]  R. Poon,et al.  Cyclin F Is Degraded during G2-M by Mechanisms Fundamentally Different from Other Cyclins* , 2002, The Journal of Biological Chemistry.

[11]  Samuel S. Wu,et al.  A statistical method for flagging weak spots improves normalization and ratio estimates in microarrays. , 2001, Physiological genomics.

[12]  E. Salmon.  Gene Expression During the Life Cycle of Drosophila melanogaster , 2002 .

[13]  S. Falkow,et al.  Cag pathogenicity island-specific responses of gastric epithelial cells to Helicobacter pylori infection , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[14]  C. Perou,et al.  Molecular portraits and the family tree of cancer , 2002, Nature Genetics.

[15]  A. Tsou,et al.  Integrative genomics based identification of potential human hepatocarcinogenesis-associated cell cycle regulators: RHAMM as an example. , 2005, Biochemical and biophysical research communications.

[16]  Christian A. Rees,et al.  Systematic variation in gene expression patterns in human cancer cell lines , 2000, Nature Genetics.

[17]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[18]  M. Terris,et al.  Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray. , 2003, The American journal of pathology.

[19]  Thomas Lengauer,et al.  Centralization: a new method for the normalization of gene expression data , 2001, ISMB.

[20]  David Botstein,et al.  The Stanford Microarray Database: data access and quality assessment tools , 2003, Nucleic Acids Res..

[21]  Ann-Ping Tsou,et al.  Overexpression of a novel imprinted gene, PEG10, in human hepatocellular carcinoma and in regenerating mouse livers. , 2003, Journal of biomedical science.

[22]  R. Nadon,et al.  Statistical issues with microarrays: processing and analysis. , 2002, Trends in genetics : TIG.

[23]  Jonathan R. Pollack,et al.  Characterizing the physical genome , 2002, Nature Genetics.

[24]  Valerie Reinke,et al.  Functional exploration of the C. elegans genome using DNA microarrays , 2002, Nature Genetics.

[25]  C. Ball,et al.  Identification of genes periodically expressed in the human cell cycle and their expression in tumors. , 2002, Molecular biology of the cell.

[26]  D. Botstein,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[27]  D. Botstein,et al.  Diversity of gene expression in adenocarcinoma of the lung , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Aled M. Edwards,et al.  Unfolding of Microarray Data , 2002, J. Comput. Biol..

[29]  David Botstein,et al.  Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia , 2001, The Journal of experimental medicine.

[30]  D. Gerhold,et al.  Better therapeutics through microarrays , 2002, Nature Genetics.

[31]  Ash A. Alizadeh,et al.  Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Vivian G. Cheung,et al.  The genetics of variation in gene expression , 2002, Nature Genetics.

[33]  S. Dudoit,et al.  STATISTICAL METHODS FOR IDENTIFYING DIFFERENTIALLY EXPRESSED GENES IN REPLICATED cDNA MICROARRAY EXPERIMENTS , 2002 .

[34]  Chi-Ying F. Huang,et al.  Identification of a novel cell cycle regulated gene, HURP, overexpressed in human hepatocellular carcinoma , 2003, Oncogene.

[35]  Andrew J. Holloway,et al.  Options available—from start to finish—for obtaining data from DNA microarrays II , 2002, Nature Genetics.

[36]  Rui Li,et al.  Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[37]  D. Botstein,et al.  Gene expression patterns in human liver cancers. , 2002, Molecular biology of the cell.

[38]  Christian A. Rees,et al.  Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[39]  H. Greenberg,et al.  Interferon alfa regulated gene expression in patients initiating interferon treatment for chronic hepatitis C , 2003, Hepatology.